1. Home
  2. CLST vs SER Comparison

CLST vs SER Comparison

Compare CLST & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLST
  • SER
  • Stock Information
  • Founded
  • CLST 1922
  • SER 2017
  • Country
  • CLST United States
  • SER United States
  • Employees
  • CLST N/A
  • SER N/A
  • Industry
  • CLST
  • SER Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLST
  • SER Health Care
  • Exchange
  • CLST Nasdaq
  • SER Nasdaq
  • Market Cap
  • CLST 51.0M
  • SER 53.5M
  • IPO Year
  • CLST N/A
  • SER 2018
  • Fundamental
  • Price
  • CLST $11.74
  • SER $5.63
  • Analyst Decision
  • CLST
  • SER Strong Buy
  • Analyst Count
  • CLST 0
  • SER 1
  • Target Price
  • CLST N/A
  • SER $11.00
  • AVG Volume (30 Days)
  • CLST 6.2K
  • SER 10.2K
  • Earning Date
  • CLST 04-24-2025
  • SER 05-08-2025
  • Dividend Yield
  • CLST N/A
  • SER N/A
  • EPS Growth
  • CLST N/A
  • SER N/A
  • EPS
  • CLST 0.57
  • SER N/A
  • Revenue
  • CLST $11,257,000.00
  • SER $51,000.00
  • Revenue This Year
  • CLST N/A
  • SER N/A
  • Revenue Next Year
  • CLST N/A
  • SER N/A
  • P/E Ratio
  • CLST $20.69
  • SER N/A
  • Revenue Growth
  • CLST 192.24
  • SER N/A
  • 52 Week Low
  • CLST $10.67
  • SER $3.81
  • 52 Week High
  • CLST $12.10
  • SER $14.57
  • Technical
  • Relative Strength Index (RSI)
  • CLST 58.53
  • SER 52.25
  • Support Level
  • CLST $11.52
  • SER $5.27
  • Resistance Level
  • CLST $11.79
  • SER $6.61
  • Average True Range (ATR)
  • CLST 0.14
  • SER 0.51
  • MACD
  • CLST 0.05
  • SER -0.03
  • Stochastic Oscillator
  • CLST 92.75
  • SER 35.53

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: